The conference "Italy - USA: International Cooperation on Emerging Biotechnologies and Life Sciences" was held in Rome a...
Over 6 million euros investment to Alkemist Bio and cell therapy with engineered T cells
Biotech company Alkemist Bio receives an investment of 6.9 million euros for the development of the first cell therapy w...
Treating autoimmune disorders with PIM Kinase, a unique approach
Mysthera Therapeutics AG use PIM kinase treating patients suffering with complex autoimmune disorders and Forty51 Ventur...
Y-Doc wins the second edition of the Synlab Group Hackathon
Y-Doc is an artificial intelligence designed to assist chronic patients and caregivers in ensuring they do not forget to...
Technology transfer. Claudia Pingue (CDP Venture Capital): Don’t create individual excellences but ecosystems
“Biotech is one of the sectors where Italy can still effectively play a decisive role and contribute to the develo...
Abrignani (INGM): “Recruiting business developers to bring science to the market”
It is necessary to recruit business developers experienced in scouting academic inventions that bring “science to ...